The Joint Graduate Program in Toxicology (JGPT) is a combined effort of Rutgers, the State University of New Jersey and the Robert Wood Johnson Medical School, and is based in the Environmental and Occupational Health Sciences Institute (EOSHI). Founded in 1981, the JGPT has trained more than 140 doctoral students, postdoctoral fellows and physician-scientists. Graduates of the JGPT have forged distinguished careers in academic, industrial and governmental toxicology research. The NIEHS T32 training grant is the driving force of the JGPT. This competitive renewal application requests funding for years 26-30 to support 6 pre-doctoral students and 3 postdoctoral fellows, including a physician-scientist. The central mission of the JGPT is to provide talented students and postdoctoral trainees with rigorous training in contemporary mechanistic toxicology and in-depth expertise in their individual field of research. The training program is highly interdisciplinary, with students performing research rotations with scientists from varied scientific backgrounds. Specialized research tracks in biochemical toxicology, cell signaling and inflammation and neurotoxicology reflect thematic areas in which JGPT faculty members are recognized as leaders. All pre-doctoral trainees perform research rotations within the EOSHI Clinic to gain experience in patient-based environmental medicine. The training is supported by an exceptional research environment centered at EOHSI that includes state-of-the-art instrumentation and strong institutional support, and that synergizes with the NIEHS Center of Excellence in Toxicology, the Cancer Institute of New Jersey, the New Jersey Institute of Food, Nutrition and Disease, the Center for Advance Biotechnology and Medicine and other units involved in environmental health research. Trainees benefit from an outstanding seminar program and close interactions with the local pharmaceutical industry. Intensive efforts are expended to attract students of outstanding quality. The training program vigorously recruits students from under-represented groups. Relevance: The unifying goal of the JGPT and this training grant is to prepare trainees to excel in the competitive and rapidly evolving arena of environmental health sciences. Toxicology is a core discipline in understanding the impact of chemicals on human health. For the last 25 years, this training grant has enabled the JGPT to develop scholars who have become leaders in academic, industrial, and governmental toxicology. Public Health Relevance: The Joint Graduate Program in Toxicology (JGPT) is a training program designed to instruct doctoral students, postdoctoral fellows and physician-scientists in the mechanisms by which exposure to chemicals in the environment cause disease in people, and to devise methods to prevent or treat these diseases. Trainees receive extensive laboratory training in laboratory techniques and emerging scientific concepts. The goal of the program is to train toxicologists to address emerging environmental health issues.

Public Health Relevance

The Joint Graduate Program in Toxicology (JGPT) is a training program designed to instruct doctoral students, postdoctoral fellows and physician-scientists in the mechanisms by which exposure to chemicals in the environment cause disease in people, and to devise methods to prevent or treat these diseases. Trainees receive extensive laboratory training in laboratory techniques and emerging scientific concepts. The goal of the program is to train toxicologists to address emerging environmental health issues.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Institutional National Research Service Award (T32)
Project #
5T32ES007148-28
Application #
8692773
Study Section
Environmental Health Sciences Review Committee (EHS)
Program Officer
Shreffler, Carol K
Project Start
1987-09-01
Project End
2017-06-30
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
28
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Rutgers University
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
City
New Brunswick
State
NJ
Country
United States
Zip Code
08901
Francis, Mary; Groves, Angela M; Sun, Richard et al. (2017) Editor's Highlight: CCR2 Regulates Inflammatory Cell Accumulation in the Lung and Tissue Injury following Ozone Exposure. Toxicol Sci 155:474-484
Francois, Lissa N; Gorczyca, Ludwik; Du, Jianyao et al. (2017) Down-regulation of the placental BCRP/ABCG2 transporter in response to hypoxia signaling. Placenta 51:57-63
Green, Ashley L; Zhan, Le; Eid, Aseel et al. (2017) Valproate increases dopamine transporter expression through histone acetylation and enhanced promoter binding of Nurr1. Neuropharmacology 125:189-196
Francis, Mary; Sun, Richard; Cervelli, Jessica A et al. (2017) Editor's Highlight: Role of Spleen-Derived Macrophages in Ozone-Induced Lung Inflammation and Injury. Toxicol Sci 155:182-195
Beier, Eric E; Neal, Matthew; Alam, Gelerah et al. (2017) Alternative microglial activation is associated with cessation of progressive dopamine neuron loss in mice systemically administered lipopolysaccharide. Neurobiol Dis 108:115-127
George, Blessy; You, Dahea; Joy, Melanie S et al. (2017) Xenobiotic transporters and kidney injury. Adv Drug Deliv Rev 116:73-91
Chang, Cara; Hu, Yichun; Hogan, Susan L et al. (2017) Pharmacogenomic Variants May Influence the Urinary Excretion of Novel Kidney Injury Biomarkers in Patients Receiving Cisplatin. Int J Mol Sci 18:
Szilagyi, John T; Vetrano, Anna M; Laskin, Jeffrey D et al. (2017) Localization of the placental BCRP/ABCG2 transporter to lipid rafts: Role for cholesterol in mediating efflux activity. Placenta 55:29-36
George, Blessy; Wen, Xia; Mercke, Nickie et al. (2017) Profiling of Kidney Injury Biomarkers in Patients Receiving Cisplatin: Time-dependent Changes in the Absence of Clinical Nephrotoxicity. Clin Pharmacol Ther 101:510-518
Sun, Runbin; Yang, Na; Kong, Bo et al. (2017) Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway. Mol Pharmacol 91:110-122

Showing the most recent 10 out of 149 publications